Full-Time

Qualified Person

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Oxford, UK

Expected to be in office 70% of the time with flexibility to work from home up to 30%.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Life Science degree and / or post-graduate.
  • 10 – 15 years of international quality experience in the biotechnology or pharmaceutical industry.
  • Must meet QP eligibility requirements combined with relevant biologics and steriles knowledge to be named on Manufacturer’s Authorisation from MHRA.
  • Meets requirements of continuing professional development required to maintain QP status.
  • Experience working in a GMP pharmaceutical / sterile / biological production environments.
  • Expert knowledge of Quality Management systems.
  • Extensive knowledge, interpretation and application of quality management within a GxP environment for early phase clinical trials & commercial products.
  • Demonstrates an in-depth understanding and proven application of the broader GMP principles, concepts, industry best practices, standards and trends.
  • Experienced Pharmaceutical Auditor.
  • Experience with hosting and participating in regulatory inspections.
  • Experience of influencing/leading others and implementing change.
Responsibilities
  • Being named as the Qualified Person on Moderna’s site licence(s).
  • Ensuring that all products are manufactured and released in compliance with EU directive 2002/83/EC.
  • Overseeing the release of biologically active intermediates and sterile products in line with cGMP, approved product descriptions, and regulatory filings.
  • Providing leadership in Quality Systems and Compliance QRM principles across the site, ensuring alignment with evolving regulatory expectations.
  • Maintaining oversight of the Quality Management System (QMS) as part of your operational responsibilities and escalating GMP concerns when necessary.
  • Representing Quality at Management Review Forum meetings and reporting on critical issues.
  • Leading self-inspections, external audits, and Quality Risk Assessments as required.
  • Delegating tasks to appropriately trained personnel or third parties and collaborating closely with the Quality Assurance team.
  • Acting as the QP point of contact for QA agreements, and reviewing and approving major/critical deviations, change proposals, and other quality records with potential batch impact.
  • Overseeing BMR and record reviews as part of the QP batch release process.
  • Keeping abreast of new and emerging regulatory guidance, ensuring company policies and procedures remain compliant.
  • Providing Quality oversight for commissioning, qualification, and validation initiatives, including complex GMP facilities and critical utility projects.
  • Collaborating cross-functionally to foster a strong Quality Culture and continuous improvement mindset.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?